STATCenter·
STAT+: New tumor cases show common gene therapy tool can come with risk
New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general.
Read at STAT →
New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general.

<iframe src="https://statesidedaily.com/embed/cluster/d1ac170ac552a167baa72fb1ff14a52557c4b83a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: New tumor cases show common gene therapy tool can come with risk"></iframe>
